MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma
Chondrosarcoma, the second most common primary malignant bone tumor, originates from cartilaginous tissue and accounts for almost 20% of all primary bone tumors. The management of chondrosarcoma remains challenging due to its diverse clinical course and prognosis, which can range from benign to high...
Main Authors: | Palina Skipar, Mritunjoy Dey, Jakub Piątkowski, Dorota Sulejczak, Piotr Rutkowski, Anna M. Czarnecka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/6/3176 |
Similar Items
-
MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin
by: Jui-Chieh Chen, et al.
Published: (2023-01-01) -
Epigenetic Abnormalities in Chondrosarcoma
by: Michał Bereza, et al.
Published: (2023-02-01) -
Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials
by: Monika Dudzisz-Śledź, et al.
Published: (2023-09-01) -
Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype
by: Agnieszka Zając, et al.
Published: (2021-03-01) -
The Biological Function of MicroRNAs in Bone Tumors
by: Sarah Adriana Scuderi, et al.
Published: (2022-02-01)